Global grains trader Bunge Ltd, which has been under pressure from activist investors, said on Monday Chief Executive Officer Soren Schroder would step down.
Schroder, who served as CEO since 2013, will continue in his current role until a successor is named, the company said in a statement.
Investors D.E. Shaw and Continental Grain have urged Bunge to expand its board, following which the company appointed the CEO of agrichemicals company Syngenta to its board.
The company has been grappling with low crop prices and the trade war that has slashed U.S. crop exports to China. Bunge was also the target of failed takeover bids rivals Archer Daniels Midland Co and commodities trader Glencore.
The grains trader also appointed Kathleen Hyle, who has served on the company’s board since 2012, as chairman, effective immediately. Hyle will be part of the search committee created to appoint a new CEO.
By Shanti S Nair
Cécile Béliot has assumed the role of Bel Group chief executive officer, following the decision to separate the roles of chairman and CEO. The separation of the functions will enable Bel Group to develop in three areas of healthy snacking. Meanwhile, the company’s former CEO, Antoine Fiévet, has had his mandate renewed as chairman of the board.
US Food and Drug Administration (FDA) Commissioner Dr. Robert Califf was grilled by lawmakers during a House Appropriations subcommittee hearing, where he was slammed over the agency’s handling of the escalating infant formula shortage.
Sweegen is ramping up its efforts to reduce sugar across F&B applications while simultaneously tapping into the benefits of using antioxidants and bitter blocking technology. Speaking to FoodIngredientsFirst, Casey McCormick, vice president of global innovation at Sweegen, says product developers can find a broad range of solutions in Sweegen’s nature-based sweetener systems as brands elevate better-for-you foods.